ProstaGene

About:

ProstaGene is a biotechnology start up company that is developing technology based on patents.

Website: http://www.prostagene.com

Twitter/X: prostagene

Description:

ProstaGene is a biotechnology start up company that is developing technology based on patents of the Founder, Dr. Richard G. Pestell. ProstaGene LLC integrates proprietary molecular diagnostics with novel therapeutic screening and commercial experience in order to develop novel treatments for cancer. ProstaGene is an early stage company that seeks to obtain financing to recruit a CEO and pursue commercialization through contracted development, partnering and out-licensing of 1) its gene-based prostate cancer testing technology and 2) its cancer metastasis prevention and treatment technology. It has filed and is prosecuting patents covering its technologies in the US and major countries around the world, and also maintains its gene signature test details as trade secrets.

Total Funding Amount:

$825000

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Wynnewood, Pennsylvania, United States

Founded Date:

2010-01-01

Contact Email:

careersprostagene(AT)gmail.com

Founders:

Richard Pestell

Number of Employees:

11-50

Last Funding Date:

2015-03-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai